- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05000437
The Effectiveness and Safety of HIIT in Overweight Male Subjects
April 13, 2022 updated by: Nani Cahyani Sudarsono, Indonesia University
The Effectiveness and Safety of High Intensity Interval Training Based on Oxidative Stress and Inflammatory Markers in the Management of Overweight Male Subjects
Increased prevalence of overweight and obesity is one of the main health problems recently.
Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals.
This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers.
This research used experimental model to test structured high intensity interval training program with pre-post test in single group.
Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety.
Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness.
Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
- Subjects are recruited via e-flyer distributed online across university departments. Individual who is interested in study participation fills out screening form. Research assistants screen subjects eligibility. Subjects are coded based on the order of screening form fulfillment.
- Research assistants are using the standard operational procedures for each assessments. Training for the research assistants precedes the data collection to ensure the similarity of understanding and skills during measurements. One research assistant responsible for scheduling the assessments and training sessions. Continuous evaluation are planned weekly to provide room for improvements in the process of data collection.
- Sample size assessment is measured from 5 primary output by a research assistants using sample size calculation website for single intervention clinical trial.
- Investigator use paper based data collection for each assessment and during training sessions. Subject are encouraged to report any symptoms and signs during intervention period in each meeting with the research assistants or via online messaging. Any reports will be documented in separated form. One research assistant makes sure the data fields are completed in each measurements and during training sessions. The assistant also check the similarity of the data entered in the master table.
- Data analysis will be lead by one research assistant using newest version of SPSS software. The analysis will be started after the baseline measurement is completed although the data collection is not finished. All numeric data will be presented as mean and standard deviations if normally distributed or median and minimum maximum range if not normally distributed. Paired t-test will be used to identify the difference before and after the intervention if the data are normally distributed. If the data are not normally distributed, Wilcoxon test will be used to identify the difference before and after the intervention.
To ensure that there is no missing data, the research assistant who responsible for data completeness will perform daily checking. Any missing data will be stated and immediately completed. Research assistants will provide close supervision for each subject to ensure the delivery of all necessary reports.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Fakultas Kedokteran Universitas Indonesia
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Universitas Indonesia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- overweight (BMI 25 - 29,9)
- live in Jakarta and greater area
- willing to participate
Exclusion Criteria:
- smoking
- any medical health problems (epilepsy, cardiovascular disease, kidney and liver problems, history of fractures, tendon and ligament injuries)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Intensity Interval Training
single arm intervention, with high intensity interval training
|
3x/week high intensity interval training for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cardiorespiratory fitness
Time Frame: 12 weeks
|
VO2Max in ml/kg/minute
|
12 weeks
|
|
body mass index
Time Frame: week 4
|
weight and height combined as BMI in kg/m2
|
week 4
|
|
body mass index
Time Frame: week 8
|
weight and height combined as BMI in kg/m2
|
week 8
|
|
body mass index
Time Frame: week 12
|
weight and height combined as BMI in kg/m2
|
week 12
|
|
body fat mass
Time Frame: week 4
|
total fat mass in the body as percentage
|
week 4
|
|
body fat mass
Time Frame: week 8
|
total fat mass in the body as percentage
|
week 8
|
|
body fat mass
Time Frame: week 12
|
total fat mass in the body as percentage
|
week 12
|
|
visceral fat
Time Frame: week 4
|
body fat stored within abdominal cavity as ratings
|
week 4
|
|
visceral fat
Time Frame: week 8
|
body fat stored within abdominal cavity as ratings
|
week 8
|
|
visceral fat
Time Frame: week 12
|
body fat stored within abdominal cavity as ratings
|
week 12
|
|
waist circumference
Time Frame: week 4
|
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
|
week 4
|
|
waist circumference
Time Frame: week 8
|
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
|
week 8
|
|
waist circumference
Time Frame: week 12
|
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
|
week 12
|
|
lipid profile
Time Frame: 12 weeks
|
total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride
|
12 weeks
|
|
antioxidant level
Time Frame: 12 weeks
|
SOD in U/mg
|
12 weeks
|
|
free radicals level
Time Frame: 12 weeks
|
MDA in nmol/mg
|
12 weeks
|
|
inflammation
Time Frame: 12 weeks
|
TNF-alpha in microgram/ml
|
12 weeks
|
|
interleukin level
Time Frame: 12 weeks
|
IL-6 nanogram/ml
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fat Burning Effect
Time Frame: week 1, 6, 12
|
FGF21
|
week 1, 6, 12
|
|
Myokin
Time Frame: week 1, 6, 12
|
Irisin
|
week 1, 6, 12
|
|
Cognitive Function Screening
Time Frame: week 1 and 12
|
Montreal Cognitive Assessment as score
|
week 1 and 12
|
|
Working memory Capacity
Time Frame: week 1 and 12
|
N-Back test as percentage of correct answers
|
week 1 and 12
|
|
Executive Function
Time Frame: week 1 and 12
|
Trail Making Test A and B as seconds
|
week 1 and 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nani Sudarsono, Fakultas Kedokteran Universitas Indonesia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Actual)
October 30, 2021
Study Completion (Anticipated)
September 30, 2022
Study Registration Dates
First Submitted
May 29, 2021
First Submitted That Met QC Criteria
August 3, 2021
First Posted (Actual)
August 11, 2021
Study Record Updates
Last Update Posted (Actual)
April 21, 2022
Last Update Submitted That Met QC Criteria
April 13, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-09-1081
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
Clinical Trials on HIIT
-
University of Erlangen-Nürnberg Medical SchoolUnknownMetabolic Syndrome | Overweight and ObesityGermany
-
Beijing Sport UniversityCompleted
-
Beijing Sport UniversityCompletedNormal Weight ObesityChina
-
Karabuk UniversityCompletedExercise Performance | Physical Fitness | Neuromuscular FunctionTurkey (Türkiye)
-
University of SevilleRecruitingInsulin Growth Factor I Deficiency | IGF1 Deficiency | Executive Function DisorderSpain
-
USDA Grand Forks Human Nutrition Research CenterCompletedObesity | OverweightUnited States
-
Karolinska InstitutetWithdrawn
-
University of Erlangen-Nürnberg Medical SchoolUnknownHealth Promotion | Primary PreventionGermany
-
Riphah International UniversityRecruiting
-
Hull University Teaching Hospitals NHS TrustTerminated